Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...